182 related articles for article (PubMed ID: 27575495)
1. Helminth Regulation of Immunity: A Three-pronged Approach to Treat Colitis.
Lopes F; Matisz C; Reyes JL; Jijon H; Al-Darmaki A; Kaplan GG; McKay DM
Inflamm Bowel Dis; 2016 Oct; 22(10):2499-512. PubMed ID: 27575495
[TBL] [Abstract][Full Text] [Related]
2. Suppression of colitis by adoptive transfer of helminth antigen-treated dendritic cells requires interleukin-4 receptor-α signaling.
Matisz CE; Faz-López B; Thomson E; Al Rajabi A; Lopes F; Terrazas LI; Wang A; Sharkey KA; McKay DM
Sci Rep; 2017 Jan; 7():40631. PubMed ID: 28094779
[TBL] [Abstract][Full Text] [Related]
3. Adoptive transfer of helminth antigen-pulsed dendritic cells protects against the development of experimental colitis in mice.
Matisz CE; Leung G; Reyes JL; Wang A; Sharkey KA; McKay DM
Eur J Immunol; 2015 Nov; 45(11):3126-39. PubMed ID: 26332354
[TBL] [Abstract][Full Text] [Related]
4. Can helminths or helminth-derived products be used in humans to prevent or treat allergic diseases?
Erb KJ
Trends Immunol; 2009 Feb; 30(2):75-82. PubMed ID: 19138565
[TBL] [Abstract][Full Text] [Related]
5. Role of helminths in regulating mucosal inflammation.
Weinstock JV; Summers RW; Elliott DE
Springer Semin Immunopathol; 2005 Sep; 27(2):249-71. PubMed ID: 15959781
[TBL] [Abstract][Full Text] [Related]
6. Young mice expel the tapeworm Hymenolepis diminuta and are protected from colitis by triggering a memory response with worm antigen.
Arai T; Lopes F; Shute A; Wang A; McKay DM
Am J Physiol Gastrointest Liver Physiol; 2018 Apr; 314(4):G461-G470. PubMed ID: 29351392
[TBL] [Abstract][Full Text] [Related]
7. Potential of human helminth therapy for resolution of inflammatory bowel disease: The future ahead.
Arai T; Lopes F
Exp Parasitol; 2022 Jan; 232():108189. PubMed ID: 34848244
[TBL] [Abstract][Full Text] [Related]
8. Review article: helminths as therapeutic agents for inflammatory bowel disease.
Hunter MM; McKay DM
Aliment Pharmacol Ther; 2004 Jan; 19(2):167-77. PubMed ID: 14723608
[TBL] [Abstract][Full Text] [Related]
9. Induction of regulatory cells by helminth parasites: exploitation for the treatment of inflammatory diseases.
Finlay CM; Walsh KP; Mills KH
Immunol Rev; 2014 May; 259(1):206-30. PubMed ID: 24712468
[TBL] [Abstract][Full Text] [Related]
10. Helminths and mucosal immune modulation.
Weinstock JV
Ann N Y Acad Sci; 2006 Aug; 1072():356-64. PubMed ID: 17057216
[TBL] [Abstract][Full Text] [Related]
11. Mast cells: new therapeutic target in helminth immune modulation.
Vukman KV; Lalor R; Aldridge A; O'Neill SM
Parasite Immunol; 2016 Jan; 38(1):45-52. PubMed ID: 26577605
[TBL] [Abstract][Full Text] [Related]
12. Helminths as governors of immune-mediated inflammation.
Elliott DE; Summers RW; Weinstock JV
Int J Parasitol; 2007 Apr; 37(5):457-64. PubMed ID: 17313951
[TBL] [Abstract][Full Text] [Related]
13. Suppression of inflammation by helminths: a role for the gut microbiota?
Giacomin P; Croese J; Krause L; Loukas A; Cantacessi C
Philos Trans R Soc Lond B Biol Sci; 2015 Aug; 370(1675):. PubMed ID: 26150662
[TBL] [Abstract][Full Text] [Related]
14. Translatability of helminth therapy in inflammatory bowel diseases.
Weinstock JV; Elliott DE
Int J Parasitol; 2013 Mar; 43(3-4):245-51. PubMed ID: 23178819
[TBL] [Abstract][Full Text] [Related]
15. Litomosoides sigmodontis induces TGF-β receptor responsive, IL-10-producing T cells that suppress bystander T-cell proliferation in mice.
Hartmann W; Schramm C; Breloer M
Eur J Immunol; 2015 Sep; 45(9):2568-81. PubMed ID: 26138667
[TBL] [Abstract][Full Text] [Related]
16. The therapeutic helminth?
McKay DM
Trends Parasitol; 2009 Mar; 25(3):109-14. PubMed ID: 19167926
[TBL] [Abstract][Full Text] [Related]
17. Worms and the treatment of inflammatory bowel disease: are molecules the answer?
Ruyssers NE; De Winter BY; De Man JG; Loukas A; Herman AG; Pelckmans PA; Moreels TG
Clin Dev Immunol; 2008; 2008():567314. PubMed ID: 18509490
[TBL] [Abstract][Full Text] [Related]
18. Not all parasites are protective.
McKay DM
Parasite Immunol; 2015 Jun; 37(6):324-32. PubMed ID: 25403350
[TBL] [Abstract][Full Text] [Related]
19. Helminth-host immunological interactions: prevention and control of immune-mediated diseases.
Elliott DE; Weinstock JV
Ann N Y Acad Sci; 2012 Jan; 1247():83-96. PubMed ID: 22239614
[TBL] [Abstract][Full Text] [Related]
20. Intestinal helminths regulate lethal acute graft-versus-host disease and preserve the graft-versus-tumor effect in mice.
Li Y; Chen HL; Bannick N; Henry M; Holm AN; Metwali A; Urban JF; Rothman PB; Weiner GJ; Blazar BR; Elliott DE; Ince MN
J Immunol; 2015 Feb; 194(3):1011-20. PubMed ID: 25527786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
